Mycobiology

The Korean Society of Mycology (한국균학회)
권호 표지
DOI QR코드

DOI QR Code

Hypoglycemic and Hypocholesterolemic Effects of Botryosphaeran from Botryosphaeria rhodina MAMB-05 in Diabetes-Induced and Hyperlipidemia Conditions in Rats

  • Miranda-Nantes, Carolina C.B.O. (Department of Biochemistry and Biotecnology, CCE, State University of Londrina) ;
  • Fonseca, Eveline A.I. (Department of Biochemistry and Biotecnology, CCE, State University of Londrina) ;
  • Zaia, Cassia T.B.V. (Department of Physiological Sciences, CCB, State University of Londrina) ;
  • Dekker, Robert F.H. (Biorefining Research Initiative, Lakehead University) ;
  • Khaper, Neelam (Medical Sciences Division, Northern Ontario School of Medicine, Lakehead University) ;
  • Castro, Inar A. (Department of Food and Experimental Nutrition, Faculty of Pharmaceutical Sciences, University of Sao Paulo) ;
  • Barbosa, Aneli M. (Department of Biochemistry and Biotecnology, CCE, State University of Londrina)
  • Received : 2011.06.10
  • Accepted : 2011.08.14
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Botryosphaeran, a water-soluble exopolysaccharide of the ${\beta}-(1{\rightarrow}3;1{\rightarrow}6)$-D-glucan type that has been isolated from the culture medium of Botryosphaeria rhodina MAMB-05 grown in submerged fermentation using glucose as the sole carbon source, was previously demonstrated to be non-genotoxic in peripheral blood and bone marrow, and exhibited strong anticlastogenic activity. In the present study, the effects of botryosphaeran were investigated in streptozotocin-induced diabetic rats as well as in high-fat diet-fed hyperlipidemic Wistar rats. The plasma glucose level was reduced by 52% in the diabetic group of rats after administration of 12 mg botryosphaeran/kg body weight of the rats (b.w.)/day by gavage over 15 days. A reduction in the median ration intake was accompanied by an increase in the median body weight gain, as well as the efficiency of food conversion. These results demonstrate that botryosphaeran has protective effects by reducing the symptoms of cachexia in Diabetes mellitus. Botryosphaeran administered by gavage at a concentration of 12 mg botryosphaeran/kg b.w./day over 15 days also reduced the plasma levels of total cholesterol and low density lipoprotein-cholesterol by 18% and 27%, respectively, in hyperlipidemic rats. Based on these findings, we conclude that botryosphaeran possesses hypoglycemic and hypocholesterolemic properties in conditions of diabetes mellitus and hyperlipidemia, respectively, and may be used as an oral anti-diabetic agent.

Keywords

References

  1. Chen J, Raymond K. Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc Health Risk Manag 2008;4:1265-72.
  2. Kim YW, Kim KH, Choi HJ, Lee DS. Anti-diabetic activity of $\beta$-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol Lett 2005;27:483-7.
  3. Chen J, Seviour R. Medicinal importance of fungal $\beta$- (1 $\rightarrow$ 3),(1 $\rightarrow$ 6)-glucans. Mycol Res 2007;111(Pt 6):635-52.
  4. Yang BK, Ha JY, Jeong SC, Jeon YJ, Ra KS, Das S, Yun JW, Song CH. Hypolipidemic effect of an exo-biopolymer produced from submerged mycelial culture of Auricularia polytricha in rats. Biotechnol Lett 2002;24:1319-25.
  5. Nicolosi R, Bell SJ, Bistrian BR, Greenberg I, Forse RA, Blackburn GL. Plasma lipid changes after supplementation with beta-glucan fiber from yeast. Am J Clin Nutr 1999;70: 208-12.
  6. Wang L, Behr SR, Newman RK, Newman CW. Comparative cholesterol-lowering effects of barley $\beta$-glucan and barley oil in golden Syrian hamsters. Nutr Res 1997;17:77-88.
  7. Barbosa AM, Steluti RM, Dekker RF, Cardoso MS, Corradi da Silva ML. Structural characterization of Botryosphaeran: a (1 $\rightarrow$ 3;1 $\rightarrow$ 6)-$\beta$-D-glucan produced by the ascomyceteous fungus, Botryosphaeria sp. Carbohydr Res 2003;338:1691-8.
  8. Giese EC, Dekker RF, Barbosa AM, da Silva R. Triple helix conformation of botryosphaeran, a (1 $\rightarrow$ 3,1 $\rightarrow$ 6)-$\beta$-D-glucan produced by Botryosphaeria rhodina MAMB-05. Carbohydr Polym 2008;74:953-6.
  9. Bohn JA, BeMiller JN. (1 $\rightarrow$ 3)-$\beta$-D-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym 1995;28:3-14.
  10. Corradi da Silva ML, Izeli NL, Martinez PF, Silva IR, Constantino CJ, Cardoso MS, Barbosa AM, Dekker RF, da Silva GV. Purification and structural characterisation of (1 $\rightarrow$ 3;1 $\rightarrow$ 6)-$\beta$-D-glucans (botryosphaerans) from Botryosphaeria rhodina grown on sucrose and fructose as carbon sources: a comparative study. Carbohydr Polym 2005; 61:10-7.
  11. Miranda CC, Dekker RF, Serpeloni JM, Fonseca EA, Cólus IM, Barbosa AM. Anticlastogenic activity exhibited by botryosphaeran, a new exopolysaccharide produced by Botryosphaeria rhodina MAMB-05. Int J Biol Macromol 2008;42:172-7.
  12. Kiho T, Morimoto H, Sakushima M, Usui S, Ukai S. Polysaccharides in fungi. XXXV. Anti diabetic activity of an acidic polysaccharide from the fruiting bodies of Tremella aurantia. Biol Pharm Bull 1995;18:1627-9.
  13. Tapola N, Karvonen H, Niskanen L, Mikola M, Sarkkinen E. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2005;15:255-61.
  14. Cheung PC. The hypocholesterolemic effect of extracellular polysaccharide from the submerged fermentation of mushroom. Nutr Res 1996;16:1953-7.
  15. Hwang HJ, Kim SW, Lim JM, Joo JH, Kim HO, Kim HM, Yun JW. Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroom Phellinus baumii in streptozotocin-induced diabetic rats. Life Sci 2005;76:3069- 80.
  16. Bolkent , Yanarda R, Tabako lu-O uz A, Özsoy-Saçan Ö. Effects of chard (Beta vulgaris L. var cicla) extract on pancreatic B cells in streptozotocin-diabetic rats: a morphological and biochemical study. J Ethnopharmacol 2000;73:251-9.
  17. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
  18. Anderson JW, Jones AE, Riddell-Mason S. Ten different dietary have significantly different effects on serum and liver lipids of cholesterol-fed rats. J Nutr 1994;124:78-83.
  19. Zulet MA, Barber A, Garcin H, Higueret P, Martínez JA. Alterations in carbohydrate and lipid metabolism induced by a diet rich in coconut oil and cholesterol in a rat model. J Am Coll Nutr 1999;18:36-42.
  20. Falholt K, Lund B, Falholt W. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta 1973;46:105-11.
  21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
  22. Onat A, Can G, Kaya H, Hergenç G. "Atherogenic index of plasma" ($log_{10}$ triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 2010;4:89-98.
  23. $Bolz\acute{a}n$ AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res 2002;512:121-34.
  24. Kiho T, Hui J, Yamane A, Ukai S. Polysaccharides in fungi. XXXII. Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis. Biol Pharm Bull 1993;16:1291-3.
  25. Kim DH, Yang BK, Jeong SC, Hur NJ, Das S, Yun JW, Choi JW, Lee YS, Song CH. A preliminary study on the hypoglycemic effect of the exo-polymers produced by five different medicinal mushrooms. J Microbiol Biotechnol 2001; 11:167-71.
  26. Yang BK, Kim GN, Jeong YT, Jeong H, Mehta P, Song CH. Hypoglycemic effects of exo-biopolymers produced by five different medicinal mushrooms in STZ-induced diabetic rats. Mycobiology 2008;36:45-9.
  27. Ohno N, lino K, Takeyama T, Suzuki I, Sato K, Oikawa S, Miyazaki T, Yadomae T. Structural characterization and antitumor activity of the extracts from matted mycelium of cultured Grifola frondosa. Chem Pharm Bull (Tokyo) 1985; 33:3395-401.
  28. Rother KI. Diabetes treatment: bridging the divide. N Engl J Med 2007;356:1499-501.
  29. Castro IA, Tirapegui J, Benedicto ML. Effects of diet supplementation with three soluble polysaccharides on serum lipid levels of hypercholesterolemic rats. Food Chem 2003; 80:323-30.
  30. Brennan CS, Cleary LJ. The potential use of cereal (1 $\rightarrow$3,1 $\rightarrow$ 4)-$\beta$-D-glucans as functional food ingredients. J Cereal Sci 2005;42:1-13.